JG
SGNT

Jefferies Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Jefferies Group’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-50,000
Closed -$1.26M – 2588
2014
Q4 		$1.26M Buy
+50,000
New +$1.47M 0.01% 886

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jefferies Group's SGNT Position: Q1 2015 in Review

Jefferies Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q1 2015, closing a stake of 12,077 shares — an estimated $303K sold.

Jefferies Group first reported a position in SGNT in Q4 2014 and held it in 1 quarter. The position peaked at $303K in Q4 2014. 127 funds tracked by Wall St. Rank hold SGNT as of Q1 2015.

  • Jefferies Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Jefferies Group sold 12,077 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $303K.
  • Jefferies Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 1 quarter.
  • Jefferies Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $303K in Q4 2014.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on Jefferies Group's 13F filing for Q1 2015, filed 18 May 2015.